OKYO Pharma Ltd (NASDAQ:OKYO) said Panetta Partners, linked to its executive chairman Gabriele Cerrone, has purchased about 10,000 shares at $1.59 each, increasing his total stake to roughly 10.5 million shares.
The latest purchase, valued at about $16,000, adds to Cerrone’s ongoing investment in the company.
The clinical-stage biotech develops therapies for neuropathic corneal pain and inflammatory eye diseases.